Providing support and services for people and families living with ALS in Ontario.
Funding high-quality research that offers the most promise to slow down ALS or even stop it.
Advocating for policy that will have a meaningful impact on people living with ALS today and in the future.
Many individuals and organizations generously give their time to create and host fundraising even...
The ALS Society of Canada (ALS Canada) is excited to welcome Dr. Leslie Green, Jude Groves, and Kris Noakes to our Board of Directors. Comprised of leadership volunteers with a variety of backgrounds and expertise, our Board ensures ALS Canada...
June 13, 2022 – Today, Amylyx Pharmaceuticals, Inc. announced that Health Canada has approved ALBRIOZA (AMX0035) under a Notice of Compliance with Conditions (NOC/c). This means the drug will soon...
Read the update